ABIVAX

abivax-logo

Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer.

#SimilarOrganizations #People #Financial #Event #Website #More

ABIVAX

Social Links:

Industry:
Biotechnology

Founded:
2013-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.abivax.com

Total Employee:
11+

Status:
Active

Contact:
+33(0)1 53 83 08 41

Email Addresses:
[email protected]

Total Funding:
96.2 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

benchmark-holdings-logo

Benchmark Holdings

Benchmark Holdings, a pioneering bioagtech company.

olix-pharmaceuticals-logo

OliX Pharmaceuticals

OliX is a clinical stage biotechnology company.

caredx-logo

CareDx

CareDx is a novel mol­e­c­u­lar diagnos­tics com­pany.


Current Advisors List

didier-blondel_image

Didier Blondel Board Secretary @ Abivax
Board_member

Current Employees Featured

jean-marc-steens_image

Jean Marc Steens
Jean Marc Steens Chief Medical Officer @ Abivax
Chief Medical Officer

pierre-courteille_image

Pierre Courteille
Pierre Courteille Founder, Chief Commercial Officer & Vice President of Business Development @ Abivax
Founder, Chief Commercial Officer & Vice President of Business Development
2015-04-01

hartmut-j-ehrlich_image

Hartmut J. Ehrlich
Hartmut J. Ehrlich CEO @ Abivax
CEO
2013-12-01

didier-blondel_image

Didier Blondel
Didier Blondel Chief Financial Officer @ Abivax
Chief Financial Officer

Founder


pierre-courteille_image

Pierre Courteille

Stock Details


Company's stock symbol is EPA:ABVX

Investors List

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Post-IPO Equity - Abivax

invus_image

Invus

Invus investment in Post-IPO Equity - Abivax

tcg-crossover_image

TCG Crossover

TCG Crossover investment in Post-IPO Equity - Abivax

truffle-capital_image

Truffle Capital

Truffle Capital investment in Post-IPO Equity - Abivax

deep-track-capital_image

Deep Track Capital

Deep Track Capital investment in Post-IPO Equity - Abivax

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Post-IPO Equity - Abivax

kreos-capital_image

Kreos Capital

Kreos Capital investment in Post-IPO Debt - Abivax

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Post-IPO Equity - Abivax

kreos-capital_image

Kreos Capital

Kreos Capital investment in Post-IPO Debt - Abivax

Key Employee Changes

Date New article
2021-03-01 Abivax appoints Dr Sophie Biguenet, M.D., as Chief Medical Officer

Official Site Inspections

http://www.abivax.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K

  • Host name: 172.67.179.74
  • IP address: 172.67.179.74
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Abivax"

About Abivax

Abivax is a clinical-stage biotechnology company focused on harnessing the body’s natural regulatory mechanisms through enhanced expression of microRNA-124. See details»

Our Pipeline - Abivax

Abivax is looking forward to evolving into a commercial-stage company through opportunities to potentially harness the novel mechanism of action of obefazimod and beyond. See details»

Abivax - Wikipedia

Abivax focuses on the treatment of inflammatory bowel diseases, namely ulcerative colitis (UC) and Crohn’s disease (CD). Its lead drug candidate, obefazimod, is an oral, first-in-class, small molecule that has demonstrated safety and tolerability as well as profound anti-inflammatory activity in preclinical as well as clinical trials in UC. See details»

Investor Relations | Abivax

Jun 2, 2025 The Investor Relations website contains information about Abivax's business for stockholders, potential investors, and financial analysts. See details»

Abivax - LinkedIn

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with ... See details»

Our Mission - Abivax

Abivax now has global headquarters in Paris, France and US headquarters in the greater Boston area. Clinical trials for obefazimod are being conducted throughout the world as shown by shaded areas on the map. We anticipate … See details»

Company History - Abivax

Abivax has a history of following the science and recognizing its potential to address unmet needs, which enables continuous exploration and future possibilities. See details»

Abivax - Crunchbase Company Profile & Funding

Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development … See details»

ABIVAX Société Anonyme (ABVX) Company Profile & Description

2 days ago Company profile for ABIVAX Société Anonyme (ABVX) stock, with a description, list of executives, contact details and other key facts. See details»

Abivax Announces Launch of Public Offering

2 days ago Abivax Announces Launch of Public Offering PARIS, France , July 23, 2025 – 10:15 p.m. (CEST) – Abivax SA ( Euronext Paris : FR0012333284 – ABVX) (“ Abivax ” or the “ … See details»

Our Leadership - Abivax

Abivax has an experienced leadership team with expertise in the scientific development and commercialization of therapeutics for chronic inflammatory diseases. See details»

ABIVAX Société Anonyme Company Description - Stock Analysis

Dec 16, 2024 Company profile for ABIVAX Société Anonyme (EPA: ABVX) with a description, list of executives, contact details and other key facts. See details»

Abivax 2025 Company Profile: Stock Performance & Earnings

Information on stock, financials, earnings, subsidiaries, investors, and executives for Abivax. Use the PitchBook Platform to explore the full profile. See details»

Abivax Company Profile - Office Locations, Competitors, Revenue

Oct 29, 2024 Abivax has 5 employees across 2 locations. See insights on Abivax including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»

Abivax SA Company Profile - Overview - GlobalData

Abivax SA: Overview Abivax SA (Abivax) is a biopharmaceutical company that primarily focuses on the discovery and development of novel treatments for chronic inflammatory diseases. The … See details»

Abivax provides operational and key program update — Sofinnova …

Jul 15, 2024 Abivax announces the appointment of Dr. Sylvie Grégoire as Chair of the Board of Directors effective immediately. Dr. Grégoire is a distinguished pharmaceutical and biotech … See details»

ABIVAX Société Anonyme (ABVX) - Yahoo Finance Canada

Find the latest ABIVAX Société Anonyme (ABVX) stock quote, history, news and other vital information to help you with your stock trading and investing. See details»

Abivax Presents First Quarter 2025 Financial Results

On January 23, 2025 in a press release titled “Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual … See details»

Abivax Stock Skyrockets On Strong Data From Inflammatory Bowel …

2 days ago Abivax SA (NASDAQ:ABVX) stock is skyrocketing on Wednesday after the clinical-stage biotechnology company announced overwhelmingly positive topline results from its Phase 3 … See details»

Abivax Hits The Stratosphere, Up Nearly 600%, On 'Potentially ...

2 days ago Shares of Abivax hit the stratosphere Wednesday after the firm unveiled "potentially disruptive" results for its ulcerative colitis drug. See details»

linkstock.net © 2022. All rights reserved